People with schizophrenia will soon have a new treatment option after the FDA approved its first new treatment for the mental ...
NBC News on MSN48m
Hezbollah strikes displace families in northern IsraelWhile the fighting intensifies between Israel and Hezbollah, there are Israeli families living near the northern border who ...
KNWA Fayetteville on MSN50m
NWA organization celebrates one million diapers given to the communityNWA organization celebrates one million diapers given to the community ...
All three indexes are on track for their third straight week of gains. Among other stocks, Bristol-Myers Squibb surged 3.2% ...
NEW YORK, Sept. 27, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers and acquirers of securities of Indivior PLC (NASDAQ: INDV) between February 22, 2024 and ...
On Thursday, the U.S. Food and Drug Administration approved COBENFY, an oral medication that marks the first new class of drugs for schizophrenia in more than 30 years.
For the first time in decades, the Food and Drug Administration has approved a new type of drug for schizophrenia. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback